Digital AI in cancer diagnostics and devices: Where we are, and wher... While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society.
Oncology Single-cell multi-omics and oncological potential Just like people, no two cancer cells are alike.
Cancer Targeting the ecosystem to make cancer extinct The ICR and The Royal Marsden have embarked on an ambitious research collaboration to disrupt the cancer cell ecosystem.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.